{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:24:55Z","timestamp":1792189495703,"version":"4.4.0"},"publisher-location":"Cham","reference-count":197,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030829834","type":"print"},{"value":"9783030829841","type":"electronic"}],"license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,3,30]],"date-time":"2021-03-30T00:00:00Z","timestamp":1617062400000},"content-version":"vor","delay-in-days":88,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Inhibitors of Na<jats:sup>+<\/jats:sup>\/Cl<jats:sup>\u2212<\/jats:sup>dependent high affinity transporters for norepinephrine (NE), serotonin (5-HT), and\/or dopamine (DA) represent frequently used drugs for treatment of psychological disorders such as depression, anxiety, obsessive-compulsive disorder, attention deficit hyperactivity disorder, and addiction. These transporters remove NE, 5-HT, and\/or DA after neuronal excitation from the interstitial space close to the synapses. Thereby they terminate transmission and modulate neuronal behavioral circuits. Therapeutic failure and undesired central nervous system side effects of these drugs have been partially assigned to neurotransmitter removal by low affinity transport. Cloning and functional characterization of the polyspecific organic cation transporters OCT1 (<jats:italic>SLC22A1<\/jats:italic>), OCT2 (<jats:italic>SLC22A2<\/jats:italic>), OCT3 (<jats:italic>SLC22A3<\/jats:italic>) and the plasma membrane monoamine transporter PMAT (<jats:italic>SLC29A4<\/jats:italic>) revealed that every single transporter mediates low affinity uptake of NE, 5-HT, and DA. Whereas the organic transporters are all located in the blood brain barrier, OCT2, OCT3, and PMAT are expressed in neurons or in neurons and astrocytes within brain areas that are involved in behavioral regulation. Areas of expression include the dorsal raphe, medullary motoric nuclei, hypothalamic nuclei, and\/or the nucleus accumbens. Current knowledge of the transport of monoamine neurotransmitters by the organic cation transporters, their interactions with psychotropic drugs, and their locations in the brain is reported in detail. In addition, animal experiments including behavior tests in wildtype and knockout animals are reported in which the impact of OCT2, OCT3, and\/or PMAT on regulation of salt intake, depression, mood control, locomotion, and\/or stress effect on addiction is suggested.<\/jats:p>","DOI":"10.1007\/164_2021_449","type":"book-chapter","created":{"date-parts":[[2021,3,29]],"date-time":"2021-03-29T17:02:47Z","timestamp":1617037367000},"page":"1-39","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["General Overview of Organic Cation Transporters in Brain"],"prefix":"10.1007","author":[{"given":"Hermann","family":"Koepsell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,30]]},"reference":[{"key":"449_CR1","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/2040-2392-5-43","volume":"5","author":"D Adamsen","year":"2014","unstructured":"Adamsen D, Ramaekers V, Ho HT, Britschgi C, Rufenacht V, Meili D, Bobrowski E, Philippe P, Nava C, Van Maldergem L, Bruggmann R, Walitza S, Wang J, Grunblatt E, Thony B (2014) Autism spectrum disorder associated with low serotonin in CSF and mutations in the SLC29A4 plasma membrane monoamine transporter (PMAT) gene. Mol Autism 5:43. https:\/\/doi.org\/10.1186\/2040-2392-5-43","journal-title":"Mol Autism"},{"key":"449_CR2","doi-asserted-by":"publisher","first-page":"5932","DOI":"10.1021\/jm8003152","volume":"51","author":"G Ahlin","year":"2008","unstructured":"Ahlin G, Karlsson J, Pedersen JM, Gustavsson L, Larsson R, Matsson P, Norinder U, Bergstr\u00f6m CAS, Artursson P (2008) Structural requirements for drug inhibition of the liver specific human organic cation transport protein. J Med Chem 51:5932\u20135942","journal-title":"J Med Chem"},{"key":"449_CR3","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/tpj.2010.54","volume":"11","author":"G Ahlin","year":"2011","unstructured":"Ahlin G, Chen L, Lazorova L, Chen Y, Ianculescu AG, Davis RL, Giacomini KM, Artursson P (2011) Genotype-dependent effects of inhibitors of the organic cation transporter, OCT1: predictions of metformin interactions. Pharmacogenomics J 11:400\u2013411","journal-title":"Pharmacogenomics J"},{"key":"449_CR4","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.neuropharm.2006.01.005","volume":"8","author":"A Amphoux","year":"2006","unstructured":"Amphoux A, Vialou V, Drescher E, Br\u00fcss M, La Cour CM, Rochat C, Millan MJ, Giros B, B\u00f6nisch H, Gautron S (2006) Differential pharmacological in vitro properties of organic cation transporters and regional distribution in rat brain. Neuropharmacology 8:941\u2013952","journal-title":"Neuropharmacology"},{"key":"449_CR5","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1124\/jpet.108.142315","volume":"327","author":"S Apparsundaram","year":"2008","unstructured":"Apparsundaram S, Stockdale DJ, Henningsen RA, Milla ME, Martin RS (2008) Antidepressants targeting the serotonin reuptake transporter act via a competitive mechanism. J Pharmacol Exp Ther 327:982\u2013990. https:\/\/doi.org\/10.1124\/jpet.108.142315","journal-title":"J Pharmacol Exp Ther"},{"key":"449_CR6","doi-asserted-by":"publisher","first-page":"F454","DOI":"10.1152\/ajprenal.2001.281.3.F454","volume":"281","author":"P Arndt","year":"2001","unstructured":"Arndt P, Volk C, Gorboulev V, Budiman T, Popp C, Ulzheimer-Teuber I, Akhoundova A, Koppatz S, Bamberg E, Nagel G, Koepsell H (2001) Interaction of cations, anions, and weak base quinine with rat renal cation transporter rOCT2 compared with rOCT1. Am J Physiol Renal Physiol 281:F454\u2013F468. https:\/\/doi.org\/10.1152\/ajprenal.2001.281.3.F454","journal-title":"Am J Physiol Renal Physiol"},{"key":"449_CR7","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s00213-005-0133-1","volume":"183","author":"RK Bachtell","year":"2005","unstructured":"Bachtell RK, Whisler K, Karanian D, Self DW (2005) Effects of intra-nucleus accumbens shell administration of dopamine agonists and antagonists on cocaine-taking and cocaine-seeking behaviors in the rat. Psychopharmacology (Berl) 183:41\u201353. https:\/\/doi.org\/10.1007\/s00213-005-0133-1","journal-title":"Psychopharmacology (Berl)"},{"key":"449_CR8","doi-asserted-by":"publisher","unstructured":"Bacq A, Balasse L, Biala G, Guiard B, Gardier AM, Schinkel A, Louis F, Vialou V, Martres MP, Chevarin C, Hamon M, Giros B, Gautron S (2012) Organic cation transporter 2 controls brain norepinephrine and serotonin clearance and antidepressant response. Mol Psychiatry 17:926\u2013939. mp201187 [pii]. https:\/\/doi.org\/10.1038\/mp.2011.87","DOI":"10.1038\/mp.2011.87"},{"key":"449_CR9","doi-asserted-by":"publisher","first-page":"18976","DOI":"10.1073\/pnas.0800466105","volume":"105","author":"NL Baganz","year":"2008","unstructured":"Baganz NL, Horton RE, Calderon AS, Owens WA, Munn JL, Watts LT, Koldzic-Zivanovic C, Jeske NA, Koek W, Toney GM, Daws LC (2008) Organic cation transporter 3: keeping the brake on extracellular serotonin in serotonin-transporter-deficient mice. Proc Natl Acad Sci U S A 105:18976\u201318981. https:\/\/doi.org\/10.1073\/pnas.0800466105","journal-title":"Proc Natl Acad Sci U S A"},{"key":"449_CR10","doi-asserted-by":"publisher","first-page":"3873","DOI":"10.1007\/s00204-017-2008-8","volume":"91","author":"M Bai","year":"2017","unstructured":"Bai M, Ma Z, Sun D, Zheng C, Weng Y, Yang X, Jiang T, Jiang H (2017) Multiple drug transporters mediate the placental transport of sulpiride. Arch Toxicol 91:3873\u20133884. https:\/\/doi.org\/10.1007\/s00204-017-2008-8","journal-title":"Arch Toxicol"},{"key":"449_CR11","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1124\/mol.63.3.489","volume":"63","author":"D Bednarczyk","year":"2003","unstructured":"Bednarczyk D, Ekins S, Wikel JH, Wright SH (2003) Influence of molecular structure on substrate binding to the human organic cation transporter, hOCT1. Mol Pharmacol 63:489\u2013498","journal-title":"Mol Pharmacol"},{"key":"449_CR12","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1124\/jpet.113.203257","volume":"346","author":"M Belzer","year":"2013","unstructured":"Belzer M, Morales M, Jagadish B, Mash EA, Wright SH (2013) Substrate-dependent ligand inhibition of the human organic cation transporter OCT2. J Pharmacol Exp Ther 346:300\u2013310. https:\/\/doi.org\/10.1124\/jpet.113.203257","journal-title":"J Pharmacol Exp Ther"},{"key":"449_CR13","doi-asserted-by":"publisher","unstructured":"Bengel D, Murphy DL, Andrews AM, Wichems CH, Feltner D, Heils A, M\u00f6ssner R, Westphal H, Lesch KP (1998) Altered brain serotonin homeostasis and locomotor insensitivity to 3, 4-methylenedioxymethamphetamine (\u201cEcstasy\u201d) in serotonin transporter-deficient mice. Mol Pharmacol 53:649\u2013655. https:\/\/doi.org\/10.1124\/mol.53.4.649","DOI":"10.1124\/mol.53.4.649"},{"key":"449_CR14","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/354066a0","volume":"354","author":"RD Blakely","year":"1991","unstructured":"Blakely RD, Berson HE, Fremeau RT Jr, Caron MG, Peek MM, Prince HK, Bradley CC (1991) Cloning and expression of a functional serotonin transporter from rat brain. Nature 354:66\u201370. https:\/\/doi.org\/10.1038\/354066a0","journal-title":"Nature"},{"key":"449_CR15","doi-asserted-by":"publisher","first-page":"e464","DOI":"10.1038\/tp.2014.90","volume":"4","author":"E Bowton","year":"2014","unstructured":"Bowton E, Saunders C, Reddy IA, Campbell NG, Hamilton PJ, Henry LK, Coon H, Sakrikar D, Veenstra-VanderWeele JM, Blakely RD, Sutcliffe J, Matthies HJ, Erreger KGalli A (2014) SLC6A3 coding variant Ala559Val found in two autism probands alters dopamine transporter function and trafficking. Transl Psychiatry 4:e464. https:\/\/doi.org\/10.1038\/tp.2014.90","journal-title":"Transl Psychiatry"},{"key":"449_CR16","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1124\/dmd.113.055095","volume":"42","author":"KH Boxberger","year":"2014","unstructured":"Boxberger KH, Hagenbuch B, Lampe JN (2014) Common drugs inhibit human organic cation transporter 1 (OCT1)-mediated neurotransmitter uptake. Drug Metab Dispos 42:990\u2013995. https:\/\/doi.org\/10.1124\/dmd.113.055095","journal-title":"Drug Metab Dispos"},{"key":"449_CR17","doi-asserted-by":"publisher","unstructured":"Boxberger KH, Hagenbuch B, Lampe JN (2018) Ligand-dependent modulation of hOCT1 transport reveals discrete ligand binding sites within the substrate translocation channel. Biochem Pharmacol 156:371\u2013384. S0006-2952(18)30354-X [pii]. https:\/\/doi.org\/10.1016\/j.bcp.2018.08.028","DOI":"10.1016\/j.bcp.2018.08.028"},{"key":"449_CR18","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/sj.bjp.0702065","volume":"125","author":"T Breidert","year":"1998","unstructured":"Breidert T, Spitzenberger F, Gr\u00fcndemann D, Sch\u00f6mig E (1998) Catecholamine transport by the organic cation transporter type 1 (OCT1). Br J Pharmacol 125:218\u2013224. https:\/\/doi.org\/10.1038\/sj.bjp.0702065","journal-title":"Br J Pharmacol"},{"key":"449_CR19","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1093\/cercor\/bhp266","volume":"20","author":"JL Brigman","year":"2010","unstructured":"Brigman JL, Mathur P, Harvey-White J, Izquierdo A, Saksida LM, Bussey TJ, Fox S, Deneris E, Murphy DL, Holmes A (2010) Pharmacological or genetic inactivation of the serotonin transporter improves reversal learning in mice. Cereb Cortex 20:1955\u20131963. https:\/\/doi.org\/10.1093\/cercor\/bhp266","journal-title":"Cereb Cortex"},{"key":"449_CR20","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1046\/j.1471-4159.2000.741241.x","volume":"74","author":"P Brust","year":"2000","unstructured":"Brust P, Friedrich A, Krizbai IA, Bergmann R, Roux F, Ganapathy V, Johannsen B (2000) Functional expression of the serotonin transporter in immortalized rat brain microvessel endothelial cells. J Neurochem 74:1241\u20131248. https:\/\/doi.org\/10.1046\/j.1471-4159.2000.741241.x","journal-title":"J Neurochem"},{"key":"449_CR21","doi-asserted-by":"publisher","first-page":"4854","DOI":"10.1523\/JNEUROSCI.18-13-04854.1998","volume":"18","author":"MA Bunin","year":"1998","unstructured":"Bunin MA, Wightman RM (1998) Quantitative evaluation of 5-hydroxytryptamine (serotonin) neuronal release and uptake: an investigation of extrasynaptic transmission. J Neurosci 18:4854\u20134860","journal-title":"J Neurosci"},{"key":"449_CR22","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/s0166-2236(99)01410-1","volume":"22","author":"MA Bunin","year":"1999","unstructured":"Bunin MA, Wightman RM (1999) Paracrine neurotransmission in the CNS: involvement of 5-HT. Trends Neurosci 22:377\u2013382. https:\/\/doi.org\/10.1016\/s0166-2236(99)01410-1","journal-title":"Trends Neurosci"},{"key":"449_CR23","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/0014-5793(96)01030-7","volume":"395","author":"AE Busch","year":"1996","unstructured":"Busch AE, Quester S, Ulzheimer JC, Gorboulev V, Akhoundova A, Waldegger S, Lang F, Koepsell H (1996) Monoamine neurotransmitter transport mediated by the polyspecific cation transporter rOCT1. FEBS Lett 395:153\u2013156","journal-title":"FEBS Lett"},{"key":"449_CR24","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1124\/mol.54.2.342","volume":"54","author":"AE Busch","year":"1998","unstructured":"Busch AE, Karbach U, Miska D, Gorboulev V, Akhoundova A, Volk C, Arndt P, Ulzheimer JC, Sonders MS, Baumann C, Waldegger S, Lang F, Koepsell H (1998) Human neurons express the polyspecific cation transporter hOCT2, which translocates monoamine neurotransmitters, amantadine, and memantine. Mol Pharmacol 54:342\u2013352","journal-title":"Mol Pharmacol"},{"key":"449_CR25","doi-asserted-by":"publisher","first-page":"3853","DOI":"10.1073\/pnas.1816247116","volume":"116","author":"NG Campbell","year":"2019","unstructured":"Campbell NG, Shekar A, Aguilar JI, Peng D, Navratna V, Yang D, Morley AN, Duran AM, Galli G, O'Grady B, Ramachandran R, Sutcliffe JS, Sitte HH, Erreger K, Meiler J, Stockner T, Bellan LM, Matthies HJG, Gouaux E, McHaourab HS, Galli A (2019) Structural, functional, and behavioral insights of dopamine dysfunction revealed by a deletion in SLC6A3. Proc Natl Acad Sci U S A 116:3853\u20133862. https:\/\/doi.org\/10.1073\/pnas.1816247116","journal-title":"Proc Natl Acad Sci U S A"},{"key":"449_CR26","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1111\/j.1471-4159.1990.tb04599.x","volume":"55","author":"E Carboni","year":"1990","unstructured":"Carboni E, Tanda GL, Frau R, Di Chiara G (1990) Blockade of the noradrenaline carrier increases extracellular dopamine concentrations in the prefrontal cortex: evidence that dopamine is taken up in vivo by noradrenergic terminals. J Neurochem 55:1067\u20131070. https:\/\/doi.org\/10.1111\/j.1471-4159.1990.tb04599.x","journal-title":"J Neurochem"},{"key":"449_CR27","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/0169-328x(93)90187-t","volume":"18","author":"C Cerruti","year":"1993","unstructured":"Cerruti C, Walther DM, Kuhar MJ, Uhl GR (1993) Dopamine transporter mRNA expression is intense in rat midbrain neurons and modest outside midbrain. Brain Res Mol Brain Res 18:181\u2013186. https:\/\/doi.org\/10.1016\/0169-328x(93)90187-t","journal-title":"Brain Res Mol Brain Res"},{"key":"449_CR28","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/s0169-328x(96)00172-6","volume":"43","author":"AS Chang","year":"1996","unstructured":"Chang AS, Chang SM, Starnes DM, Schroeter S, Bauman AL, Blakely RD (1996) Cloning and expression of the mouse serotonin transporter. Brain Res Mol Brain Res 43:185\u2013192. https:\/\/doi.org\/10.1016\/s0169-328x(96)00172-6","journal-title":"Brain Res Mol Brain Res"},{"key":"449_CR29","doi-asserted-by":"publisher","unstructured":"Chaves C, Campanelli F, Chapy H, Gomez-Zepeda D, Glacial F, Smirnova M, Taghi M, Pallud J, Perriere N, Decleves X, Menet MC, Cisternino S (2020) An interspecies molecular and functional study of organic cation transporters at the blood-brain barrier: from rodents to humans. Pharmaceutics 12. https:\/\/doi.org\/10.3390\/pharmaceutics12040308","DOI":"10.3390\/pharmaceutics12040308"},{"key":"449_CR30","doi-asserted-by":"publisher","unstructured":"Chen L, Shu Y, Liang X, Chen EC, Yee SW, Zur AA, Li S, Xu L, Keshari KR, Lin MJ, Chien HC, Zhang Y, Morrissey KM, Liu J, Ostrem J, Younger NS, Kurhanewicz J, Shokat KM, Ashrafi K, Giacomini KM (2014) OCT1 is a high-capacity thiamine transporter that regulates hepatic steatosis and is a target of metformin. Proc Natl Acad Sci U S A 111:9983\u20139988. 1314939111 [pii]. https:\/\/doi.org\/10.1073\/pnas.1314939111","DOI":"10.1073\/pnas.1314939111"},{"key":"449_CR31","doi-asserted-by":"publisher","first-page":"2685","DOI":"10.1021\/acs.jmedchem.6b01317","volume":"60","author":"EC Chen","year":"2017","unstructured":"Chen EC, Khuri N, Liang X, Stecula A, Chien HC, Yee SW, Huang Y, Sali A, Giacomini KM (2017a) Discovery of competitive and noncompetitive ligands of the organic cation transporter 1 (OCT1; SLC22A1). J Med Chem 60:2685\u20132696. https:\/\/doi.org\/10.1021\/acs.jmedchem.6b01317","journal-title":"J Med Chem"},{"key":"449_CR32","doi-asserted-by":"publisher","unstructured":"Chen J, Brockm\u00f6ller J, Seitz T, K\u00f6nig J, Chen X, Tzvetkov MV (2017b) Tropane alkaloids as substrates and inhibitors of human organic cation transporters of the SLC22 (OCT) and the SLC47 (MATE) families. Biol Chem 398:237\u2013249. https:\/\/doi.org\/10.1515\/hsz-2016-0236. j\/bchm.just-accepted\/hsz-2016-0236\/hsz-2016-0236.xml [pii]","DOI":"10.1515\/hsz-2016-0236"},{"key":"449_CR33","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1124\/dmd.31.11.1337","volume":"31","author":"S Choudhuri","year":"2003","unstructured":"Choudhuri S, Cherrington NJ, Li N, Klaassen CD (2003) Constitutive expression of various xenobiotic and endobiotic transporter mRNAs in the choroid plexus of rats. Drug Metab Dispos 31:1337\u20131345","journal-title":"Drug Metab Dispos"},{"key":"449_CR34","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1523\/JNEUROSCI.15-03-01714.1995","volume":"15","author":"BJ Ciliax","year":"1995","unstructured":"Ciliax BJ, Heilman C, Demchyshyn LL, Pristupa ZB, Ince E, Hersch SM, Niznik HB, Levey AI (1995) The dopamine transporter: immunochemical characterization and localization in brain. J Neurosci 15:1714\u20131723","journal-title":"J Neurosci"},{"key":"449_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1476-5381.1969.tb09515.x","volume":"37","author":"DE Clarke","year":"1969","unstructured":"Clarke DE, Jones CJ, Linley PA (1969) Histochemical fluorescence studies on noradrenaline accumulation by Uptake 2 in the isolated rat heart. Br J Pharmacol 37:1\u20139. https:\/\/doi.org\/10.1111\/j.1476-5381.1969.tb09515.x","journal-title":"Br J Pharmacol"},{"key":"449_CR36","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/s0166-2236(96)10024-2","volume":"19","author":"JD Clements","year":"1996","unstructured":"Clements JD (1996) Transmitter timecourse in the synaptic cleft: its role in central synaptic function. Trends Neurosci 19:163\u2013171. https:\/\/doi.org\/10.1016\/s0166-2236(96)10024-2","journal-title":"Trends Neurosci"},{"key":"449_CR37","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/s0301-0082(96)00033-0","volume":"50","author":"Z Cohen","year":"1996","unstructured":"Cohen Z, Bonvento G, Lacombe P, Hamel E (1996) Serotonin in the regulation of brain microcirculation. Prog Neurobiol 50:335\u2013362. https:\/\/doi.org\/10.1016\/s0301-0082(96)00033-0","journal-title":"Prog Neurobiol"},{"key":"449_CR38","doi-asserted-by":"publisher","unstructured":"Courousse T, Gautron S (2015) Role of organic cation transporters (OCTs) in the brain. Pharmacol Ther 146:94\u2013103. S0163-7258(14)00170-3 [pii]. https:\/\/doi.org\/10.1016\/j.pharmthera.2014.09.008","DOI":"10.1016\/j.pharmthera.2014.09.008"},{"key":"449_CR39","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1038\/mp.2014.86","volume":"7","author":"T Courousse","year":"2014","unstructured":"Courousse T, Bacq A, Belzung C, Guiard B, Balasse L, Louis F, Le Guisquet AM, Gardier AM, Schinkel AH, Giros B, Gautron S (2014) Brain organic cation transporter 2 controls response and vulnerability to stress and GSK3beta signaling. Mol Psychiatry 7:889\u2013900. mp201486 [pii]. https:\/\/doi.org\/10.1038\/mp.2014.86","journal-title":"Mol Psychiatry"},{"key":"449_CR40","doi-asserted-by":"publisher","unstructured":"Cui M, Aras R, Christian WV, Rappold PM, Hatwar M, Panza J, Jackson-Lewis V, Javitch JA, Ballatori N, Przedborski S, Tieu K (2009) The organic cation transporter-3 is a pivotal modulator of neurodegeneration in the nigrostriatal dopaminergic pathway. Proc Natl Acad Sci U S A 106:8043\u20138048. 0900358106 [pii]. https:\/\/doi.org\/10.1073\/pnas.0900358106","DOI":"10.1073\/pnas.0900358106"},{"key":"449_CR41","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/j.neuroscience.2007.01.072","volume":"146","author":"A Dahlin","year":"2007","unstructured":"Dahlin A, Xia L, Kong W, Hevner R, Wang J (2007) Expression and immunolocalization of the plasma membrane monoamine transporter in the brain. Neuroscience 146:1193\u20131211. https:\/\/doi.org\/10.1016\/j.neuroscience.2007.01.072","journal-title":"Neuroscience"},{"key":"449_CR42","doi-asserted-by":"publisher","unstructured":"Dahlin A, Royall J, Hohmann JG, Wang J (2009) Expression profiling of the solute carrier gene family in the mouse brain. J Pharmacol Exp Ther 329:558\u2013570. jpet.108.149831 [pii]. https:\/\/doi.org\/10.1124\/jpet.108.149831","DOI":"10.1124\/jpet.108.149831"},{"key":"449_CR43","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/s0896-6273(03)00568-3","volume":"39","author":"W Dauer","year":"2003","unstructured":"Dauer W, Przedborski S (2003) Parkinson\u2019s disease: mechanisms and models. Neuron 39:889\u2013909. https:\/\/doi.org\/10.1016\/s0896-6273(03)00568-3","journal-title":"Neuron"},{"key":"449_CR44","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1038\/sj.bjp.0705538","volume":"140","author":"DJ David","year":"2003","unstructured":"David DJ, Bourin M, Jego G, Przybylski C, Jolliet P, Gardier AM (2003) Effects of acute treatment with paroxetine, citalopram and venlafaxine in vivo on noradrenaline and serotonin outflow: a microdialysis study in Swiss mice. Br J Pharmacol 140:1128\u20131136. https:\/\/doi.org\/10.1038\/sj.bjp.0705538. sj.bjp.0705538 [pii]","journal-title":"Br J Pharmacol"},{"key":"449_CR45","doi-asserted-by":"publisher","unstructured":"Daws LC (2009) Unfaithful neurotransmitter transporters: focus on serotonin uptake and implications for antidepressant efficacy. Pharmacol Ther 121:89\u201399. https:\/\/doi.org\/10.1016\/j.pharmathera.2008.10.004","DOI":"10.1016\/j.pharmathera.2008.10.004"},{"key":"449_CR46","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.pharmthera.2011.03.013","volume":"131","author":"LC Daws","year":"2011","unstructured":"Daws LC, Gould GG (2011) Ontogeny and regulation of the serotonin transporter: providing insights into human disorders. Pharmacol Ther 131:61\u201379. https:\/\/doi.org\/10.1016\/j.pharmthera.2011.03.013","journal-title":"Pharmacol Ther"},{"key":"449_CR47","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/nn.3039","volume":"15","author":"ES Deneris","year":"2012","unstructured":"Deneris ES, Wyler SC (2012) Serotonergic transcriptional networks and potential importance to mental health. Nat Neurosci 15:519\u2013527. https:\/\/doi.org\/10.1038\/nn.3039","journal-title":"Nat Neurosci"},{"key":"449_CR48","doi-asserted-by":"publisher","unstructured":"dos Santos Pereira JN, Tadjerpisheh S, Abu AM, Saadatmand AR, Weksler B, Romero IA, Couraud PO, Brockm\u00f6ller J, Tzvetkov MV (2014) The poorly membrane permeable antipsychotic drugs amisulpride and sulpiride are substrates of the organic cation transporters from the SLC22 family. AAPS J 16:1247\u20131258. https:\/\/doi.org\/10.1208\/s12248-014-9649-9","DOI":"10.1208\/s12248-014-9649-9"},{"key":"449_CR49","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1073\/pnas.0805517106","volume":"106","author":"JC Dreher","year":"2009","unstructured":"Dreher JC, Kohn P, Kolachana B, Weinberger DR, Berman KF (2009) Variation in dopamine genes influences responsivity of the human reward system. Proc Natl Acad Sci U S A 106:617\u2013622. https:\/\/doi.org\/10.1073\/pnas.0805517106","journal-title":"Proc Natl Acad Sci U S A"},{"key":"449_CR50","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1124\/jpet.110.170142","volume":"335","author":"H Duan","year":"2010","unstructured":"Duan H, Wang J (2010) Selective transport of monoamine neurotransmitters by human plasma membrane monoamine transporter and organic cation transporter 3. J Pharmacol Exp Ther 335:743\u2013753. https:\/\/doi.org\/10.1124\/jpet.110.170142","journal-title":"J Pharmacol Exp Ther"},{"key":"449_CR51","doi-asserted-by":"publisher","first-page":"3535","DOI":"10.1074\/jbc.M112.436972","volume":"288","author":"H Duan","year":"2013","unstructured":"Duan H, Wang J (2013) Impaired monoamine and organic cation uptake in choroid plexus in mice with targeted disruption of the plasma membrane monoamine transporter (Slc29a4) gene. J Biol Chem 288:3535\u20133544. https:\/\/doi.org\/10.1074\/jbc.M112.436972","journal-title":"J Biol Chem"},{"key":"449_CR52","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1124\/dmd.115.064824","volume":"43","author":"H Duan","year":"2015","unstructured":"Duan H, Hu T, Foti RS, Pan Y, Swaan PW, Wang J (2015) Potent and selective inhibition of plasma membrane monoamine transporter by HIV protease inhibitors. Drug Metab Dispos 43:1773\u20131780. https:\/\/doi.org\/10.1124\/dmd.115.064824","journal-title":"Drug Metab Dispos"},{"key":"449_CR53","doi-asserted-by":"publisher","unstructured":"Engel K, Wang J (2005) Interaction of organic cations with a newly identified plasma membrane monoamine transporter. Mol Pharmacol 68:1397\u20131407. mol.105.016832 [pii]. https:\/\/doi.org\/10.1124\/mol.105.016832","DOI":"10.1124\/mol.105.016832"},{"key":"449_CR54","doi-asserted-by":"publisher","first-page":"50042","DOI":"10.1074\/jbc.M407913200","volume":"279","author":"K Engel","year":"2004","unstructured":"Engel K, Zhou M, Wang J (2004) Identification and characterization of a novel monoamine transporter in the human brain. J Biol Chem 279:50042\u201350049. https:\/\/doi.org\/10.1074\/jbc.M407913200","journal-title":"J Biol Chem"},{"key":"449_CR55","first-page":"312","volume":"45","author":"AJ Eshleman","year":"1994","unstructured":"Eshleman AJ, Henningsen RA, Neve KA, Janowsky A (1994) Release of dopamine via the human transporter. Mol Pharmacol 45:312\u2013316","journal-title":"Mol Pharmacol"},{"key":"449_CR56","doi-asserted-by":"publisher","unstructured":"Floerl S, Kuehne A, Hagos Y (2020) Functional and pharmacological comparison of human, mouse, and rat organic cation transporter 1 toward drug and pesticide interaction. Int J Mol Sci 21. https:\/\/doi.org\/10.3390\/ijms21186871","DOI":"10.3390\/ijms21186871"},{"key":"449_CR57","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.ejphar.2018.10.028","volume":"842","author":"R Fraser-Spears","year":"2019","unstructured":"Fraser-Spears R, Krause-Heuer AM, Basiouny M, Mayer FP, Manishimwe R, Wyatt NA, Dobrowolski JC, Roberts MP, Greguric I, Kumar N, Koek W, Sitte HH, Callaghan PD, Fraser BH, Daws LC (2019) Comparative analysis of novel decynium-22 analogs to inhibit transport by the low-affinity, high-capacity monoamine transporters, organic cation transporters 2 and 3, and plasma membrane monoamine transporter. Eur J Pharmacol 842:351\u2013364. https:\/\/doi.org\/10.1016\/j.ejphar.2018.10.028","journal-title":"Eur J Pharmacol"},{"key":"449_CR58","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1002\/cne.903590211","volume":"359","author":"C Freed","year":"1995","unstructured":"Freed C, Revay R, Vaughan RA, Kriek E, Grant S, Uhl GR, Kuhar MJ (1995) Dopamine transporter immunoreactivity in rat brain. J Comp Neurol 359:340\u2013349. https:\/\/doi.org\/10.1002\/cne.903590211","journal-title":"J Comp Neurol"},{"key":"449_CR59","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.phrs.2018.07.010","volume":"140","author":"VR Garbarino","year":"2019","unstructured":"Garbarino VR, Gilman TL, Daws LC, Gould GG (2019) Extreme enhancement or depletion of serotonin transporter function and serotonin availability in autism spectrum disorder. Pharmacol Res 140:85\u201399. https:\/\/doi.org\/10.1016\/j.phrs.2018.07.010","journal-title":"Pharmacol Res"},{"key":"449_CR60","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1523\/JNEUROSCI.14-01-00442.1994","volume":"14","author":"PA Garris","year":"1994","unstructured":"Garris PA, Wightman RM (1994) Different kinetics govern dopaminergic transmission in the amygdala, prefrontal cortex, and striatum: an in vivo voltammetric study. J Neurosci 14:442\u2013450","journal-title":"J Neurosci"},{"key":"449_CR61","doi-asserted-by":"publisher","first-page":"6084","DOI":"10.1523\/JNEUROSCI.14-10-06084.1994","volume":"14","author":"PA Garris","year":"1994","unstructured":"Garris PA, Ciolkowski EL, Pastore P, Wightman RM (1994) Efflux of dopamine from the synaptic cleft in the nucleus accumbens of the rat brain. J Neurosci 14:6084\u20136093","journal-title":"J Neurosci"},{"key":"449_CR62","doi-asserted-by":"publisher","first-page":"8758","DOI":"10.1523\/JNEUROSCI.0570-06.2006","volume":"26","author":"PJ Gasser","year":"2006","unstructured":"Gasser PJ, Lowry CA, Orchinik M (2006) Corticosterone-sensitive monoamine transport in the rat dorsomedial hypothalamus: potential role for organic cation transporter 3 in stress-induced modulation of monoaminergic neurotransmission. J Neurosci 26:8758\u20138766. https:\/\/doi.org\/10.1523\/JNEUROSCI.0570-06.2006","journal-title":"J Neurosci"},{"key":"449_CR63","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1002\/cne.21921","volume":"512","author":"PJ Gasser","year":"2009","unstructured":"Gasser PJ, Orchinik M, Raju I, Lowry CA (2009) Distribution of organic cation transporter 3, a corticosterone-sensitive monoamine transporter, in the rat brain. J Comp Neurol 512:529\u2013555. https:\/\/doi.org\/10.1002\/cne.21921","journal-title":"J Comp Neurol"},{"key":"449_CR64","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1007\/s00429-016-1315-9","volume":"222","author":"PJ Gasser","year":"2017","unstructured":"Gasser PJ, Hurley MM, Chan J, Pickel VM (2017) Organic cation transporter 3 (OCT3) is localized to intracellular and surface membranes in select glial and neuronal cells within the basolateral amygdaloid complex of both rats and mice. Brain Struct Funct 222:1913\u20131928. https:\/\/doi.org\/10.1007\/s00429-016-1315-9","journal-title":"Brain Struct Funct"},{"key":"449_CR65","doi-asserted-by":"publisher","unstructured":"Geier EG, Chen EC, Webb A, Papp AC, Yee SW, Sadee W, Giacomini KM (2013) Profiling solute carrier transporters in the human blood-brain barrier. Clin Pharmacol Ther 94:636\u2013639. clpt2013175 [pii]. https:\/\/doi.org\/10.1038\/clpt.2013.175","DOI":"10.1038\/clpt.2013.175"},{"key":"449_CR66","doi-asserted-by":"publisher","unstructured":"Gilman TL, George CM, Vitela M, Herrera-Rosales M, Basiouny MS, Koek W, Daws LC (2018) Constitutive plasma membrane monoamine transporter (PMAT, Slc29a4) deficiency subtly affects anxiety-like and coping behaviours. Eur J Neurosci. https:\/\/doi.org\/10.1111\/ejn.13968","DOI":"10.1111\/ejn.13968"},{"key":"449_CR67","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/0014-5793(91)81406-x","volume":"295","author":"B Giros","year":"1991","unstructured":"Giros B, el Mestikawy S, Bertrand L, Caron MG (1991) Cloning and functional characterization of a cocaine-sensitive dopamine transporter. FEBS Lett 295:149\u2013154. https:\/\/doi.org\/10.1016\/0014-5793(91)81406-x","journal-title":"FEBS Lett"},{"key":"449_CR68","first-page":"383","volume":"42","author":"B Giros","year":"1992","unstructured":"Giros B, el Mestikawy S, Godinot N, Zheng K, Han H, Yang-Feng T, Caron MG (1992) Cloning, pharmacological characterization, and chromosome assignment of the human dopamine transporter. Mol Pharmacol 42:383\u2013390","journal-title":"Mol Pharmacol"},{"key":"449_CR69","doi-asserted-by":"publisher","first-page":"15985","DOI":"10.1016\/S0021-9258(17)33961-3","volume":"269","author":"B Giros","year":"1994","unstructured":"Giros B, Wang YM, Suter S, McLeskey SB, Pifl C, Caron MG (1994) Delineation of discrete domains for substrate, cocaine, and tricyclic antidepressant interactions using chimeric dopamine-norepinephrine transporters. J Biol Chem 269:15985\u201315988","journal-title":"J Biol Chem"},{"key":"449_CR70","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/379606a0","volume":"379","author":"B Giros","year":"1996","unstructured":"Giros B, Jaber M, Jones SR, Wightman RM, Caron MG (1996) Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379:606\u2013612. https:\/\/doi.org\/10.1038\/379606a0","journal-title":"Nature"},{"key":"449_CR71","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1089\/dna.1997.16.871","volume":"16","author":"V Gorboulev","year":"1997","unstructured":"Gorboulev V, Ulzheimer JC, Akhoundova A, Ulzheimer-Teuber I, Karbach U, Quester S, Baumann C, Lang F, Busch AE, Koepsell H (1997) Cloning and characterization of two human polyspecific organic cation transporters. DNA Cell Biol 16:871\u2013881. https:\/\/doi.org\/10.1089\/dna.1997.16.871","journal-title":"DNA Cell Biol"},{"key":"449_CR72","doi-asserted-by":"publisher","first-page":"11800","DOI":"10.1523\/JNEUROSCI.1969-13.2013","volume":"33","author":"EN Graf","year":"2013","unstructured":"Graf EN, Wheeler RA, Baker DA, Ebben AL, Hill JE, McReynolds JR, Robble MA, Vranjkovic O, Wheeler DS, Mantsch JR, Gasser PJ (2013) Corticosterone acts in the nucleus accumbens to enhance dopamine signaling and potentiate reinstatement of cocaine seeking. J Neurosci 33:11800\u201311810. https:\/\/doi.org\/10.1523\/JNEUROSCI.1969-13.2013","journal-title":"J Neurosci"},{"key":"449_CR73","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/372549a0","volume":"372","author":"D Gr\u00fcndemann","year":"1994","unstructured":"Gr\u00fcndemann D, Gorboulev V, Gambaryan S, Veyhl M, Koepsell H (1994) Drug excretion mediated by a new prototype of polyspecific transporter. Nature 372:549\u2013552. https:\/\/doi.org\/10.1038\/372549a0","journal-title":"Nature"},{"key":"449_CR74","doi-asserted-by":"publisher","first-page":"10408","DOI":"10.1074\/jbc.272.16.10408","volume":"272","author":"D Gr\u00fcndemann","year":"1997","unstructured":"Gr\u00fcndemann D, Babin-Ebell J, Martel F, Ording N, Schmidt A, Sch\u00f6mig E (1997) Primary structure and functional expression of the apical organic cation transporter from kidney epithelial LLC-PK1 cells. J Biol Chem 272:10408\u201310413. https:\/\/doi.org\/10.1074\/jbc.272.16.10408","journal-title":"J Biol Chem"},{"key":"449_CR75","doi-asserted-by":"publisher","first-page":"30915","DOI":"10.1074\/jbc.273.47.30915","volume":"273","author":"D Gr\u00fcndemann","year":"1998","unstructured":"Gr\u00fcndemann D, Koster S, Kiefer N, Breidert T, Engelhardt M, Spitzenberger F, Oberm\u00fcller N, Sch\u00f6mig E (1998a) Transport of monoamine transmitters by the organic cation transporter type 2, OCT2. J Biol Chem 273:30915\u201330920. https:\/\/doi.org\/10.1074\/jbc.273.47.30915","journal-title":"J Biol Chem"},{"key":"449_CR76","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/1557","volume":"1","author":"D Gr\u00fcndemann","year":"1998","unstructured":"Gr\u00fcndemann D, Schechinger B, Rappold GA, Sch\u00f6mig E (1998b) Molecular identification of the corticosterone-sensitive extraneuronal catecholamine transporter. Nat Neurosci 1:349\u2013351. https:\/\/doi.org\/10.1038\/1557","journal-title":"Nat Neurosci"},{"key":"449_CR77","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1038\/sj.bjp.0704926","volume":"137","author":"D Gr\u00fcndemann","year":"2002","unstructured":"Gr\u00fcndemann D, Koschker AC, Haag C, Honold C, Zimmermann T, Sch\u00f6mig E (2002) Activation of the extraneuronal monoamine transporter (EMT) from rat expressed in 293 cells. Br J Pharmacol 137:910\u2013918. https:\/\/doi.org\/10.1038\/sj.bjp.0704926","journal-title":"Br J Pharmacol"},{"key":"449_CR78","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/j.1471-4159.2004.02180.x","volume":"88","author":"C Haag","year":"2004","unstructured":"Haag C, Berkels R, Gr\u00fcndemann D, Lazar A, Taubert D, Sch\u00f6mig E (2004) The localisation of the extraneuronal monoamine transporter (EMT) in rat brain. J Neurochem 88:291\u2013297","journal-title":"J Neurochem"},{"key":"449_CR79","doi-asserted-by":"publisher","first-page":"e0136451","DOI":"10.1371\/journal.pone.0136451","volume":"10","author":"K Hacker","year":"2015","unstructured":"Hacker K, Maas R, Kornhuber J, Fromm MF, Zolk O (2015) Substrate-dependent inhibition of the human organic cation transporter OCT2: a comparison of metformin with experimental substrates. PLoS One 10:e0136451. https:\/\/doi.org\/10.1371\/journal.pone.0136451. PONE-D-15-16754 [pii]","journal-title":"PLoS One"},{"key":"449_CR80","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s00210-009-0479-8","volume":"381","author":"B Haenisch","year":"2010","unstructured":"Haenisch B, B\u00f6nisch H (2010) Interaction of the human plasma membrane monoamine transporter (hPMAT) with antidepressants and antipsychotics. Naunyn Schmiedebergs Arch Pharmacol 381:33\u201339. https:\/\/doi.org\/10.1007\/s00210-009-0479-8","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"449_CR81","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1038\/mp.2013.102","volume":"18","author":"PJ Hamilton","year":"2013","unstructured":"Hamilton PJ, Campbell NG, Sharma S, Erreger K, Herborg Hansen F, Saunders C, Belovich AN, Consortium NAAS, Sahai MA, Cook EH, Gether U, McHaourab HS, Matthies HJ, Sutcliffe JS, Galli A (2013) De novo mutation in the dopamine transporter gene associates dopamine dysfunction with autism spectrum disorder. Mol Psychiatry 18:1315\u20131323. https:\/\/doi.org\/10.1038\/mp.2013.102","journal-title":"Mol Psychiatry"},{"key":"449_CR82","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ejphar.2004.07.098","volume":"499","author":"H Hasannejad","year":"2004","unstructured":"Hasannejad H, Takeda M, Narikawa S, Huang X-L, Enomoto A, Taki K, Niwa T, Jung SH, Onozato ML, Tojo A, Endou H (2004) Human organic cation transporter 3 mediates the transport of antiarrhythmic drugs. Eur J Pharmacol 499:45\u201351","journal-title":"Eur J Pharmacol"},{"key":"449_CR83","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/sj.bjp.0704785","volume":"136","author":"M Hayer-Zillgen","year":"2002","unstructured":"Hayer-Zillgen M, Br\u00fcss M, B\u00f6nisch H (2002) Expression and pharmacological profile of the human organic cation transporters hOCT1, hOCT2 and hOCT3. Br J Pharmacol 136:829\u2013836","journal-title":"Br J Pharmacol"},{"key":"449_CR84","doi-asserted-by":"publisher","first-page":"7232","DOI":"10.1021\/jm400966v","volume":"56","author":"R Hendrickx","year":"2013","unstructured":"Hendrickx R, Johansson JG, Lohmann C, Jenvert RM, Blomgren A, Borjesson L, Gustavsson L (2013) Identification of novel substrates and structure-activity relationship of cellular uptake mediated by human organic cation transporters 1 and 2. J Med Chem 56:7232\u20137242. https:\/\/doi.org\/10.1021\/jm400966v","journal-title":"J Med Chem"},{"key":"449_CR85","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1002\/(SICI)1096-9861(19971117)388:2<211::AID-CNE3>3.0.CO;2-4","volume":"388","author":"SM Hersch","year":"1997","unstructured":"Hersch SM, Yi H, Heilman CJ, Edwards RH, Levey AI (1997) Subcellular localization and molecular topology of the dopamine transporter in the striatum and substantia nigra. J Comp Neurol 388:211\u2013227","journal-title":"J Comp Neurol"},{"key":"449_CR86","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jchemneu.2013.04.007","volume":"52","author":"JE Hill","year":"2013","unstructured":"Hill JE, Gasser PJ (2013) Organic cation transporter 3 is densely expressed in the intercalated cell groups of the amygdala: anatomical evidence for a stress hormone-sensitive dopamine clearance system. J Chem Neuroanat 52:36\u201343. https:\/\/doi.org\/10.1016\/j.jchemneu.2013.04.007","journal-title":"J Chem Neuroanat"},{"key":"449_CR87","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1006\/frne.1998.0168","volume":"19","author":"BJ Hoffman","year":"1998","unstructured":"Hoffman BJ, Hansson SR, Mezey E, Palkovits M (1998) Localization and dynamic regulation of biogenic amine transporters in the mammalian central nervous system. Front Neuroendocrinol 19:187\u2013231. https:\/\/doi.org\/10.1006\/frne.1998.0168","journal-title":"Front Neuroendocrinol"},{"key":"449_CR88","doi-asserted-by":"publisher","unstructured":"Holleran KM, Rose JH, Fordahl SC, Benton KC, Rohr KE, Gasser PJ, Jones SR (2020) Organic cation transporter 3 and the dopamine transporter differentially regulate catecholamine uptake in the basolateral amygdala and nucleus accumbens. Eur J Neurosci. https:\/\/doi.org\/10.1111\/ejn.14927","DOI":"10.1111\/ejn.14927"},{"key":"449_CR89","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1113\/jphysiol.2014.285312","volume":"593","author":"PS Hosford","year":"2015","unstructured":"Hosford PS, Millar J, Ramage AG (2015) Cardiovascular afferents cause the release of 5-HT in the nucleus tractus solitarii; this release is regulated by the low- (PMAT) not the high-affinity transporter (SERT). J Physiol 593:1715\u20131729. https:\/\/doi.org\/10.1113\/jphysiol.2014.285312","journal-title":"J Physiol"},{"key":"449_CR90","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1124\/dmd.111.042432","volume":"40","author":"S Itagaki","year":"2012","unstructured":"Itagaki S, Ganapathy V, Ho HT, Zhou M, Babu E, Wang J (2012) Electrophysiological characterization of the polyspecific organic cation transporter plasma membrane monoamine transporter. Drug Metab Dispos 40:1138\u20131143. https:\/\/doi.org\/10.1124\/dmd.111.042432","journal-title":"Drug Metab Dispos"},{"key":"449_CR91","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/j.1476-5381.1965.tb01753.x","volume":"25","author":"LL Iversen","year":"1965","unstructured":"Iversen LL (1965) The uptake of catechol amines at high perfusion concentrations in the rat isolated heart: a novel catechol amine uptake process. Br J Pharmacol Chemother 25:18\u201333. https:\/\/doi.org\/10.1111\/j.1476-5381.1965.tb01753.x","journal-title":"Br J Pharmacol Chemother"},{"key":"449_CR92","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1111\/j.1476-5381.1971.tb07066.x","volume":"41","author":"LL Iversen","year":"1971","unstructured":"Iversen LL (1971) Role of transmitter uptake mechanisms in synaptic neurotransmission. Br J Pharmacol 41:571\u2013591. https:\/\/doi.org\/10.1111\/j.1476-5381.1971.tb07066.x","journal-title":"Br J Pharmacol"},{"key":"449_CR93","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1073\/pnas.82.7.2173","volume":"82","author":"JA Javitch","year":"1985","unstructured":"Javitch JA, D'Amato RJ, Strittmatter SM, Snyder SH (1985) Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity. Proc Natl Acad Sci U S A 82:2173\u20132177","journal-title":"Proc Natl Acad Sci U S A"},{"key":"449_CR94","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1523\/JNEUROSCI.18-06-01979.1998","volume":"18","author":"SR Jones","year":"1998","unstructured":"Jones SR, Gainetdinov RR, Wightman RM, Caron MG (1998) Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter. J Neurosci 18:1979\u20131986","journal-title":"J Neurosci"},{"key":"449_CR95","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1111\/j.1471-4159.1987.tb00973.x","volume":"49","author":"RN Kalaria","year":"1987","unstructured":"Kalaria RN, Harik SI (1987) Blood-brain barrier monoamine oxidase: enzyme characterization in cerebral microvessels and other tissues from six mammalian species, including human. J Neurochem 49:856\u2013864. https:\/\/doi.org\/10.1111\/j.1471-4159.1987.tb00973.x","journal-title":"J Neurochem"},{"key":"449_CR96","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1021\/acs.molpharmaceut.7b00627","volume":"15","author":"M Keiser","year":"2018","unstructured":"Keiser M, Hasan M, Oswald S (2018) Affinity of ketamine to clinically relevant transporters. Mol Pharm 15:326\u2013331. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.7b00627","journal-title":"Mol Pharm"},{"key":"449_CR97","doi-asserted-by":"publisher","first-page":"15971","DOI":"10.1074\/jbc.273.26.15971","volume":"273","author":"R Kekuda","year":"1998","unstructured":"Kekuda R, Prasad PD, Wu X, Wang H, Fei YJ, Leibach FH, Ganapathy V (1998) Cloning and functional characterization of a potential-sensitive, polyspecific organic cation transporter (OCT3) most abundantly expressed in placenta. J Biol Chem 273:15971\u201315979. https:\/\/doi.org\/10.1074\/jbc.273.26.15971","journal-title":"J Biol Chem"},{"key":"449_CR98","doi-asserted-by":"publisher","first-page":"4548","DOI":"10.1021\/jm2001629","volume":"54","author":"Y Kido","year":"2011","unstructured":"Kido Y, Matsson P, Giacomini KM (2011) Profiling of a prescription drug library for potential renal drug-drug interactions mediated by the organic cation transporter 2. J Med Chem 54:4548\u20134558","journal-title":"J Med Chem"},{"key":"449_CR99","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1126\/science.1948035","volume":"254","author":"JE Kilty","year":"1991","unstructured":"Kilty JE, Lorang D, Amara SG (1991) Cloning and expression of a cocaine-sensitive rat dopamine transporter. Science 254:578\u2013579. https:\/\/doi.org\/10.1126\/science.1948035","journal-title":"Science"},{"key":"449_CR100","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.neulet.2005.03.014","volume":"382","author":"K Kitaichi","year":"2005","unstructured":"Kitaichi K, Fukuda M, Nakayama H, Aoyama N, Ito Y, Fujimoto Y, Takagi K, Takagi K, Hasegawa T (2005) Behavioral changes following antisense oligonucleotide-induced reduction of organic cation transporter-3 in mice. Neurosci Lett 382:195\u2013200","journal-title":"Neurosci Lett"},{"key":"449_CR101","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1515\/hsz-2018-0191","volume":"400","author":"H Koepsell","year":"2019","unstructured":"Koepsell H (2019) Multiple binding sites in organic cation transporters require sophisticated procedures to identify interactions of novel drugs. Biol Chem 400:195\u2013207. https:\/\/doi.org\/10.1515\/hsz-2018-0191","journal-title":"Biol Chem"},{"key":"449_CR102","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1124\/pr.118.015578","volume":"72","author":"H Koepsell","year":"2020","unstructured":"Koepsell H (2020) Organic cation transporters in health and disease. Pharmacol Rev 72:253\u2013319. https:\/\/doi.org\/10.1124\/pr.118.015578","journal-title":"Pharmacol Rev"},{"key":"449_CR103","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1007\/s11095-007-9254-z","volume":"24","author":"H Koepsell","year":"2007","unstructured":"Koepsell H, Lips K, Volk C (2007) Polyspecific organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications. Pharm Res 24:1227\u20131251","journal-title":"Pharm Res"},{"key":"449_CR104","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1038\/nature07455","volume":"455","author":"V Krishnan","year":"2008","unstructured":"Krishnan V, Nestler EJ (2008) The molecular neurobiology of depression. Nature 455:894\u2013902. https:\/\/doi.org\/10.1038\/nature07455","journal-title":"Nature"},{"key":"449_CR105","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1124\/pr.108.000869","volume":"63","author":"AS Kristensen","year":"2011","unstructured":"Kristensen AS, Andersen J, Jorgensen TN, Sorensen L, Eriksen J, Loland CJ, Stromgaard K, Gether U (2011) SLC6 neurotransmitter transporters: structure, function, and regulation. Pharmacol Rev 63:585\u2013640. https:\/\/doi.org\/10.1124\/pr.108.000869","journal-title":"Pharmacol Rev"},{"key":"449_CR106","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.neuron.2012.09.013","volume":"76","author":"KP Lesch","year":"2012","unstructured":"Lesch KP, Waider J (2012) Serotonin in the modulation of neural plasticity and networks: implications for neurodevelopmental disorders. Neuron 76:175\u2013191. https:\/\/doi.org\/10.1016\/j.neuron.2012.09.013","journal-title":"Neuron"},{"key":"449_CR107","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1098\/rstb.2012.0039","volume":"367","author":"KP Lesch","year":"2012","unstructured":"Lesch KP, Araragi N, Waider J, van den Hove D, Gutknecht L (2012) Targeting brain serotonin synthesis: insights into neurodevelopmental disorders with long-term outcomes related to negative emotionality, aggression and antisocial behaviour. Philos Trans R Soc Lond B Biol Sci 367:2426\u20132443. https:\/\/doi.org\/10.1098\/rstb.2012.0039","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"449_CR108","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/sj.jcbfm.9600001","volume":"25","author":"L Leybaert","year":"2005","unstructured":"Leybaert L (2005) Neurobarrier coupling in the brain: a partner of neurovascular and neurometabolic coupling? J Cereb Blood Flow Metab 25:2\u201316. https:\/\/doi.org\/10.1038\/sj.jcbfm.9600001","journal-title":"J Cereb Blood Flow Metab"},{"key":"449_CR109","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1002\/bdd.2104","volume":"38","author":"L Li","year":"2017","unstructured":"Li L, Weng Y, Wang W, Bai M, Lei H, Zhou H, Jiang H (2017) Multiple organic cation transporters contribute to the renal transport of sulpiride. Biopharm Drug Dispos 38:526\u2013534. https:\/\/doi.org\/10.1002\/bdd.2104","journal-title":"Biopharm Drug Dispos"},{"key":"449_CR110","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1111\/j.1471-4159.2010.06801.x","volume":"114","author":"C-J Lin","year":"2010","unstructured":"Lin C-J, Tai Y, Huang M-T, Tsai Y-F, Hsu H-J, Tzen K-Y, Liou H-H (2010) Cellular localization of the organic cation transporters, OCT1 and OCT2, in brain microvessel endothelial cells and its implication for MPTP transport across the blood-brain barrier and MPTP-induced dopaminergic toxicity in rodents. J Neurochem 114:717\u2013727","journal-title":"J Neurochem"},{"key":"449_CR111","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1002\/syn.20023","volume":"52","author":"LA Liprando","year":"2004","unstructured":"Liprando LA, Miner LH, Blakely RD, Lewis DA, Sesack SR (2004) Ultrastructural interactions between terminals expressing the norepinephrine transporter and dopamine neurons in the rat and monkey ventral tegmental area. Synapse 52:233\u2013244. https:\/\/doi.org\/10.1002\/syn.20023","journal-title":"Synapse"},{"key":"449_CR112","doi-asserted-by":"publisher","first-page":"4903","DOI":"10.1523\/JNEUROSCI.14-08-04903.1994","volume":"14","author":"D Lorang","year":"1994","unstructured":"Lorang D, Amara SG, Simerly RB (1994) Cell-type-specific expression of catecholamine transporters in the rat brain. J Neurosci 14:4903\u20134914","journal-title":"J Neurosci"},{"key":"449_CR113","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1523\/JNEUROSCI.1342-09.2010","volume":"30","author":"A Madayag","year":"2010","unstructured":"Madayag A, Kau KS, Lobner D, Mantsch JR, Wisniewski S, Baker DA (2010) Drug-induced plasticity contributing to heightened relapse susceptibility: neurochemical changes and augmented reinstatement in high-intake rats. J Neurosci 30:210\u2013217. https:\/\/doi.org\/10.1523\/JNEUROSCI.1342-09.2010","journal-title":"J Neurosci"},{"key":"449_CR114","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1111\/j.1471-4159.1984.tb00902.x","volume":"43","author":"C Maruki","year":"1984","unstructured":"Maruki C, Spatz M, Ueki Y, Nagatsu I, Bembry J (1984) Cerebrovascular endothelial cell culture: metabolism and synthesis of 5-hydroxytryptamine. J Neurochem 43:316\u2013319. https:\/\/doi.org\/10.1111\/j.1471-4159.1984.tb00902.x","journal-title":"J Neurochem"},{"key":"449_CR115","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.jneumeth.2004.05.017","volume":"140","author":"TA Mathews","year":"2004","unstructured":"Mathews TA, Fedele DE, Coppelli FM, Avila AM, Murphy DL, Andrews AM (2004) Gene dose-dependent alterations in extraneuronal serotonin but not dopamine in mice with reduced serotonin transporter expression. J Neurosci Methods 140:169\u2013181. https:\/\/doi.org\/10.1016\/j.jneumeth.2004.05.017","journal-title":"J Neurosci Methods"},{"key":"449_CR116","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1002\/cpt.317","volume":"99","author":"J Matthaei","year":"2016","unstructured":"Matthaei J, Kuron D, Faltraco F, Knoch T, dos Santos Pereira JN, Abu AM, Prukop T, Brockm\u00f6ller J, Tzvetkov MV (2016) OCT1 mediates hepatic uptake of sumatriptan and loss-of-function OCT1 polymorphisms affect sumatriptan pharmacokinetics. Clin Pharmacol Ther 99:633\u2013641. https:\/\/doi.org\/10.1002\/cpt.317","journal-title":"Clin Pharmacol Ther"},{"key":"449_CR117","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.1038\/s41386-018-0053-5","volume":"43","author":"FP Mayer","year":"2018","unstructured":"Mayer FP, Schmid D, Owens WA, Gould GG, Apuschkin M, Kudlacek O, Salzer I, Boehm S, Chiba P, Williams PH, Wu HH, Gether U, Koek W, Daws LC, Sitte HH (2018) An unsuspected role for organic cation transporter 3 in the actions of amphetamine. Neuropsychopharmacology 43:2408\u20132417. https:\/\/doi.org\/10.1038\/s41386-018-0053-5","journal-title":"Neuropsychopharmacology"},{"key":"449_CR118","doi-asserted-by":"publisher","unstructured":"Mazei-Robinson MS, Blakely RD (2006) ADHD and the dopamine transporter: are there reasons to pay attention? Handb Exp Pharmacol:373\u2013415. https:\/\/doi.org\/10.1007\/3-540-29784-7_17","DOI":"10.1007\/3-540-29784-7_17"},{"key":"449_CR119","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.neuropharm.2005.08.003","volume":"49","author":"MS Mazei-Robison","year":"2005","unstructured":"Mazei-Robison MS, Couch RS, Shelton RC, Stein MA, Blakely RD (2005) Sequence variation in the human dopamine transporter gene in children with attention deficit hyperactivity disorder. Neuropharmacology 49:724\u2013736. https:\/\/doi.org\/10.1016\/j.neuropharm.2005.08.003","journal-title":"Neuropharmacology"},{"key":"449_CR120","doi-asserted-by":"publisher","first-page":"7040","DOI":"10.1523\/JNEUROSCI.0473-08.2008","volume":"28","author":"MS Mazei-Robison","year":"2008","unstructured":"Mazei-Robison MS, Bowton E, Holy M, Schmudermaier M, Freissmuth M, Sitte HH, Galli A, Blakely RD (2008) Anomalous dopamine release associated with a human dopamine transporter coding variant. J Neurosci 28:7040\u20137046. https:\/\/doi.org\/10.1523\/JNEUROSCI.0473-08.2008","journal-title":"J Neurosci"},{"key":"449_CR121","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1016\/s1734-1140(13)71522-6","volume":"65","author":"J Mika","year":"2013","unstructured":"Mika J, Zychowska M, Makuch W, Rojewska E, Przewlocka B (2013) Neuronal and immunological basis of action of antidepressants in chronic pain \u2013 clinical and experimental studies. Pharmacol Rep 65:1611\u20131621. https:\/\/doi.org\/10.1016\/s1734-1140(13)71522-6","journal-title":"Pharmacol Rep"},{"key":"449_CR122","first-page":"565","volume":"298","author":"MJ Millan","year":"2001","unstructured":"Millan MJ, Gobert A, Lejeune F, Newman-Tancredi A, Rivet JM, Auclair A, Peglion JL (2001) S33005, a novel ligand at both serotonin and norepinephrine transporters: I. Receptor binding, electrophysiological, and neurochemical profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine. J Pharmacol Exp Ther 298:565\u2013580","journal-title":"J Pharmacol Exp Ther"},{"key":"449_CR123","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1124\/dmd.109.028142","volume":"38","author":"T Minematsu","year":"2010","unstructured":"Minematsu T, Iwai M, Umehara K-I, Usui T, Kamimura H (2010) Characterization of human organic cation transporter 1 (OCT1\/SLC22A1)- and OCT2 (SLC22A2)-mediated transport of 1-(2-methoxyethyl)-2-methyl-4,9-dioxo-3-(pyrazin-2-ylmethyl)- 4,9-dihydro-1H-naphtho[2,3-d]imidazolium bromide (YM155 monobromide), a novel small molecule survivin suppressant. Drug Metab Dispos 38:1\u20134","journal-title":"Drug Metab Dispos"},{"key":"449_CR124","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1002\/2211-5463.12183","volume":"7","author":"Y Miura","year":"2017","unstructured":"Miura Y, Yoshikawa T, Naganuma F, Nakamura T, Iida T, Karpati A, Matsuzawa T, Mogi A, Harada R, Yanai K (2017) Characterization of murine polyspecific monoamine transporters. FEBS Open Bio 7:237\u2013248. https:\/\/doi.org\/10.1002\/2211-5463.12183","journal-title":"FEBS Open Bio"},{"key":"449_CR125","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1523\/JNEUROSCI.22-02-00389.2002","volume":"22","author":"JA Moron","year":"2002","unstructured":"Moron JA, Brockington A, Wise RA, Rocha BA, Hope BT (2002) Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines. J Neurosci 22:389\u2013395","journal-title":"J Neurosci"},{"key":"449_CR126","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s00210-007-0181-7","volume":"376","author":"A Muck","year":"2007","unstructured":"Muck A, Gilsbach R, Lobbe-Werner S, Bruss M, B\u00f6nisch H (2007) Molecular cloning and functional expression of the murine noradrenaline transporter. Naunyn Schmiedebergs Arch Pharmacol 376:65\u201371. https:\/\/doi.org\/10.1007\/s00210-007-0181-7","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"449_CR127","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1016\/j.bcp.2005.09.011","volume":"70","author":"J M\u00fcller","year":"2005","unstructured":"M\u00fcller J, Lips KS, Metzner L, Neubert RHH, Koepsell H, Brandsch M (2005) Drug specificity and intestinal membrane localization of human organic cation transporters (OCT). Biochem Pharmacol 70:1851\u20131860","journal-title":"Biochem Pharmacol"},{"key":"449_CR128","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.brainres.2007.09.072","volume":"1184","author":"H Nakayama","year":"2007","unstructured":"Nakayama H, Kitaichi K, Ito Y, Hashimoto K, Takagi K, Yokoi T, Takagi K, Ozaki N, Yamamoto T, Hasegawa T (2007) The role of organic cation transporter-3 in methamphetamine disposition and its behavioral response in rats. Brain Res 1184:260\u2013269","journal-title":"Brain Res"},{"key":"449_CR129","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s00210-007-0219-x","volume":"376","author":"AT Nies","year":"2008","unstructured":"Nies AT, Herrmann E, Brom M, Keppler D (2008) Vectorial transport of the plant alkaloid berberine by double-transfected cells expressing the human organic cation transporter 1 (OCT1, SLC22A1) and the efflux pump MDR1 P-glycoprotein (ABCB1). Naunyn Schmiedebergs Arch Pharmacol 376:449\u2013461","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"449_CR130","doi-asserted-by":"publisher","unstructured":"Nies AT, Koepsell H, Damme K, Schwab M (2011) Organic cation transporters (OCTs, MATEs), in vitro and in vivo evidence for the importance in drug therapy. Handb Exp Pharmacol:105\u2013167. https:\/\/doi.org\/10.1007\/978-3-642-14541-4_3","DOI":"10.1007\/978-3-642-14541-4_3"},{"key":"449_CR131","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1523\/JNEUROSCI.16-02-00436.1996","volume":"16","author":"MJ Nirenberg","year":"1996","unstructured":"Nirenberg MJ, Vaughan RA, Uhl GR, Kuhar MJ, Pickel VM (1996) The dopamine transporter is localized to dendritic and axonal plasma membranes of nigrostriatal dopaminergic neurons. J Neurosci 16:436\u2013447","journal-title":"J Neurosci"},{"key":"449_CR132","doi-asserted-by":"publisher","first-page":"6899","DOI":"10.1523\/JNEUROSCI.17-18-06899.1997","volume":"17","author":"MJ Nirenberg","year":"1997","unstructured":"Nirenberg MJ, Chan J, Pohorille A, Vaughan RA, Uhl GR, Kuhar MJ, Pickel VM (1997a) The dopamine transporter: comparative ultrastructure of dopaminergic axons in limbic and motor compartments of the nucleus accumbens. J Neurosci 17:6899\u20136907","journal-title":"J Neurosci"},{"key":"449_CR133","doi-asserted-by":"publisher","first-page":"5255","DOI":"10.1523\/JNEUROSCI.17-14-05255.1997","volume":"17","author":"MJ Nirenberg","year":"1997","unstructured":"Nirenberg MJ, Chan J, Vaughan RA, Uhl GR, Kuhar MJ, Pickel VM (1997b) Immunogold localization of the dopamine transporter: an ultrastructural study of the rat ventral tegmental area. J Neurosci 17:5255\u20135262","journal-title":"J Neurosci"},{"key":"449_CR134","doi-asserted-by":"publisher","first-page":"3924","DOI":"10.1002\/jps.22594","volume":"100","author":"T Okura","year":"2011","unstructured":"Okura T, Kato S, Takano Y, Sato T, Yamashita A, Morimoto R, Ohtsuki S, Terasaki T, Deguchi Y (2011) Functional characterization of rat plasma membrane monoamine transporter in the blood-brain and blood-cerebrospinal fluid barriers. J Pharm Sci 100:3924\u20133938. https:\/\/doi.org\/10.1002\/jps.22594","journal-title":"J Pharm Sci"},{"key":"449_CR135","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1038\/s41380-019-0548-4","volume":"25","author":"A Orrico-Sanchez","year":"2020","unstructured":"Orrico-Sanchez A, Chausset-Boissarie L, Alves de Sousa R, Coutens B, Rezai Amin S, Vialou V, Louis F, Hessani A, Dansette PM, Zornoza T, Gruszczynski C, Giros B, Guiard BP, Acher F, Pietrancosta N, Gautron S (2020) Antidepressant efficacy of a selective organic cation transporter blocker in a mouse model of depression. Mol Psychiatry 25:1245\u20131259. https:\/\/doi.org\/10.1038\/s41380-019-0548-4","journal-title":"Mol Psychiatry"},{"key":"449_CR136","first-page":"1305","volume":"283","author":"MJ Owens","year":"1997","unstructured":"Owens MJ, Morgan WN, Plott SJ, Nemeroff CB (1997) Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites. J Pharmacol Exp Ther 283:1305\u20131322","journal-title":"J Pharmacol Exp Ther"},{"key":"449_CR137","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/350350a0","volume":"350","author":"T Pacholczyk","year":"1991","unstructured":"Pacholczyk T, Blakely RD, Amara SG (1991) Expression cloning of a cocaine- and antidepressant-sensitive human noradrenaline transporter. Nature 350:350\u2013354. https:\/\/doi.org\/10.1038\/350350a0","journal-title":"Nature"},{"key":"449_CR138","first-page":"761","volume":"290","author":"FA Paczkowski","year":"1999","unstructured":"Paczkowski FA, Bryan-Lluka LJ, Porzgen P, Bruss M, B\u00f6nisch H (1999) Comparison of the pharmacological properties of cloned rat, human, and bovine norepinephrine transporters. J Pharmacol Exp Ther 290:761\u2013767","journal-title":"J Pharmacol Exp Ther"},{"key":"449_CR139","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/0165-6147(91)90583-e","volume":"12","author":"AA Parsons","year":"1991","unstructured":"Parsons AA (1991) 5-HT receptors in human and animal cerebrovasculature. Trends Pharmacol Sci 12:310\u2013315. https:\/\/doi.org\/10.1016\/0165-6147(91)90583-e","journal-title":"Trends Pharmacol Sci"},{"key":"449_CR140","doi-asserted-by":"publisher","first-page":"7356","DOI":"10.1523\/JNEUROSCI.19-17-07356.1999","volume":"19","author":"VM Pickel","year":"1999","unstructured":"Pickel VM, Chan J (1999) Ultrastructural localization of the serotonin transporter in limbic and motor compartments of the nucleus accumbens. J Neurosci 19:7356\u20137366","journal-title":"J Neurosci"},{"key":"449_CR141","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.psc.2014.05.006","volume":"37","author":"C Pittenger","year":"2014","unstructured":"Pittenger C, Bloch MH (2014) Pharmacological treatment of obsessive-compulsive disorder. Psychiatr Clin North Am 37:375\u2013391. https:\/\/doi.org\/10.1016\/j.psc.2014.05.006","journal-title":"Psychiatr Clin North Am"},{"key":"449_CR142","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1523\/JNEUROSCI.15-02-01261.1995","volume":"15","author":"Y Qian","year":"1995","unstructured":"Qian Y, Melikian HE, Rye DB, Levey AI, Blakely RD (1995) Identification and characterization of antidepressant-sensitive serotonin transporter proteins using site-specific antibodies. J Neurosci 15:1261\u20131274","journal-title":"J Neurosci"},{"key":"449_CR143","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1126\/science.482930","volume":"206","author":"JF Reinhard Jr","year":"1979","unstructured":"Reinhard JF Jr, Liebmann JE, Schlosberg AJ, Moskowitz MA (1979) Serotonin neurons project to small blood vessels in the brain. Science 206:85\u201387. https:\/\/doi.org\/10.1126\/science.482930","journal-title":"Science"},{"key":"449_CR144","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1002\/(SICI)1098-2396(199602)22:2<93::AID-SYN1>3.0.CO;2-C","volume":"22","author":"R Revay","year":"1996","unstructured":"Revay R, Vaughan R, Grant S, Kuhar MJ (1996) Dopamine transporter immunohistochemistry in median eminence, amygdala, and other areas of the rat brain. Synapse 22:93\u201399. https:\/\/doi.org\/10.1002\/(SICI)1098-2396(199602)22:2<93::AID-SYN1>3.0.CO;2-C","journal-title":"Synapse"},{"key":"449_CR145","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1124\/mol.117.111443","volume":"94","author":"PJ Sandoval","year":"2018","unstructured":"Sandoval PJ, Zorn KM, Clark AM, Ekins S, Wright SH (2018) Assessment of substrate-dependent ligand interactions at the organic cation transporter OCT2 using six model substrates. Mol Pharmacol 94:1057\u20131068. mol.117.111443 [pii]. https:\/\/doi.org\/10.1124\/mol.117.111443","journal-title":"Mol Pharmacol"},{"key":"449_CR146","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1124\/jpet.105.086827","volume":"315","author":"R Sata","year":"2005","unstructured":"Sata R, Ohtani H, Tsujimoto M, Murakami H, Koyabu N, Nakamura T, Uchiumi T, Kuwano M, Nagata H, Tsukimori K, Nakano H, Sawada Y (2005) Functional analysis of organic cation transporter 3 expressed in human placenta. J Pharmacol Exp Ther 315:888\u2013895","journal-title":"J Pharmacol Exp Ther"},{"key":"449_CR147","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1002\/jnr.10521","volume":"71","author":"A Schmitt","year":"2003","unstructured":"Schmitt A, M\u00f6ssner R, Gossmann A, Fischer IG, Gorboulev V, Murphy DL, Koepsell H, Lesch KP (2003) Organic cation transporter capable of transporting serotonin is up-regulated in serotonin transporter-deficient mice. J Neurosci Res 71:701\u2013709","journal-title":"J Neurosci Res"},{"key":"449_CR148","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1002\/(SICI)1096-9861(20000501)420:2<211::AID-CNE5>3.0.CO;2-3","volume":"420","author":"S Schroeter","year":"2000","unstructured":"Schroeter S, Apparsundaram S, Wiley RG, Miner LH, Sesack SR, Blakely RD (2000) Immunolocalization of the cocaine- and antidepressant-sensitive l-norepinephrine transporter. J Comp Neurol 420:211\u2013232","journal-title":"J Comp Neurol"},{"key":"449_CR149","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12987-019-0158-1","volume":"16","author":"GN Sekhar","year":"2019","unstructured":"Sekhar GN, Fleckney AL, Boyanova ST, Rupawala H, Lo R, Wang H, Farag DB, Rahman KM, Broadstock M, Reeves S, Thomas SA (2019) Region-specific blood-brain barrier transporter changes leads to increased sensitivity to amisulpride in Alzheimer's disease. Fluids Barriers CNS 16:38. https:\/\/doi.org\/10.1186\/s12987-019-0158-1","journal-title":"Fluids Barriers CNS"},{"key":"449_CR150","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1126\/science.1948034","volume":"254","author":"S Shimada","year":"1991","unstructured":"Shimada S, Kitayama S, Lin C-L, Patel A, Nanthakumar E, Gregor P, Kuhar M, Uhl G (1991) Cloning and expression of a cocaine-sensitive dopamine transporter complementary DNA. Science 254:576\u2013578","journal-title":"Science"},{"key":"449_CR151","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.jchemneu.2016.09.006","volume":"83\u201384","author":"Y Shirasaka","year":"2017","unstructured":"Shirasaka Y, Lee N, Duan H, Ho H, Pak J, Wang J (2017) Interspecies comparison of the functional characteristics of plasma membrane monoamine transporter (PMAT) between human, rat and mouse. J Chem Neuroanat 83\u201384:99\u2013106. https:\/\/doi.org\/10.1016\/j.jchemneu.2016.09.006","journal-title":"J Chem Neuroanat"},{"key":"449_CR152","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s00213-003-1525-8","volume":"170","author":"R Sinha","year":"2003","unstructured":"Sinha R, Talih M, Malison R, Cooney N, Anderson GM, Kreek MJ (2003) Hypothalamic-pituitary-adrenal axis and sympatho-adreno-medullary responses during stress-induced and drug cue-induced cocaine craving states. Psychopharmacology (Berl) 170:62\u201372. https:\/\/doi.org\/10.1007\/s00213-003-1525-8","journal-title":"Psychopharmacology (Berl)"},{"key":"449_CR153","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.tips.2014.11.006","volume":"36","author":"HH Sitte","year":"2015","unstructured":"Sitte HH, Freissmuth M (2015) Amphetamines, new psychoactive drugs and the monoamine transporter cycle. Trends Pharmacol Sci 36:41\u201350. https:\/\/doi.org\/10.1016\/j.tips.2014.11.006","journal-title":"Trends Pharmacol Sci"},{"key":"449_CR154","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1046\/j.1471-4159.1998.71031289.x","volume":"71","author":"HH Sitte","year":"1998","unstructured":"Sitte HH, Huck S, Reither H, Boehm S, Singer EA, Pifl C (1998) Carrier-mediated release, transport rates, and charge transfer induced by amphetamine, tyramine, and dopamine in mammalian cells transfected with the human dopamine transporter. J Neurochem 71:1289\u20131297. https:\/\/doi.org\/10.1046\/j.1471-4159.1998.71031289.x","journal-title":"J Neurochem"},{"key":"449_CR155","doi-asserted-by":"publisher","first-page":"5720","DOI":"10.1073\/pnas.91.12.5720","volume":"91","author":"JF Smiley","year":"1994","unstructured":"Smiley JF, Levey AI, Ciliax BJ, Goldman-Rakic PS (1994) D1 dopamine receptor immunoreactivity in human and monkey cerebral cortex: predominant and extrasynaptic localization in dendritic spines. Proc Natl Acad Sci U S A 91:5720\u20135724. https:\/\/doi.org\/10.1073\/pnas.91.12.5720","journal-title":"Proc Natl Acad Sci U S A"},{"key":"449_CR156","doi-asserted-by":"publisher","first-page":"e2006571","DOI":"10.1371\/journal.pbio.2006571","volume":"17","author":"W Song","year":"2019","unstructured":"Song W, Luo Q, Zhang Y, Zhou L, Liu Y, Ma Z, Guo J, Huang Y, Cheng L, Meng Z, Li Z, Zhang B, Li S, Yee SW, Fan H, Li P, Giacomini KM, Chen L (2019) Organic cation transporter 3 (Oct3) is a distinct catecholamines clearance route in adipocytes mediating the beiging of white adipose tissue. PLoS Biol 17:e2006571. https:\/\/doi.org\/10.1371\/journal.pbio.2006571. pbio.2006571 [pii]","journal-title":"PLoS Biol"},{"key":"449_CR157","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuron.2005.03.013","volume":"46","author":"D Sulzer","year":"2005","unstructured":"Sulzer D, Edwards RH (2005) Antidepressants and the monoamine masquerade. Neuron 46:1\u20132. https:\/\/doi.org\/10.1016\/j.neuron.2005.03.013","journal-title":"Neuron"},{"key":"449_CR158","doi-asserted-by":"publisher","first-page":"4102","DOI":"10.1523\/JNEUROSCI.15-05-04102.1995","volume":"15","author":"D Sulzer","year":"1995","unstructured":"Sulzer D, Chen TK, Lau YY, Kristensen H, Rayport S, Ewing A (1995) Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport. J Neurosci 15:4102\u20134108","journal-title":"J Neurosci"},{"key":"449_CR159","doi-asserted-by":"publisher","unstructured":"Sun S, Wang K, Lei H, Li L, Tu M, Zeng S, Zhou H, Jiang H (2014) Inhibition of organic cation transporter 2 and 3 may be involved in the mechanism of the antidepressant-like action of berberine. Prog Neuropsychopharmacol Biol Psychiatry 49:1\u20136. S0278-5846(13)00248-0 [pii]. https:\/\/doi.org\/10.1016\/j.pnpbp.2013.11.005","DOI":"10.1016\/j.pnpbp.2013.11.005"},{"key":"449_CR160","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/0306-4522(96)00030-9","volume":"73","author":"C Sur","year":"1996","unstructured":"Sur C, Betz H, Schloss P (1996) Immunocytochemical detection of the serotonin transporter in rat brain. Neuroscience 73:217\u2013231. https:\/\/doi.org\/10.1016\/0306-4522(96)00030-9","journal-title":"Neuroscience"},{"key":"449_CR161","doi-asserted-by":"publisher","first-page":"41611","DOI":"10.1074\/jbc.M108472200","volume":"276","author":"DH Sweet","year":"2001","unstructured":"Sweet DH, Miller DS, Pritchard JB (2001) Ventricular choline transport: a role for organic cation transporter 2 expressed in choroid plexus. J Biol Chem 276:41611\u201341619. https:\/\/doi.org\/10.1074\/jbc.M108472200","journal-title":"J Biol Chem"},{"key":"449_CR162","doi-asserted-by":"publisher","unstructured":"Takano H, Ito S, Zhang X, Ito H, Zhang MR, Suzuki H, Maeda K, Kusuhara H, Suhara T, Sugiyama Y. (2017) Possible role of organic cation transporters in the distribution of [11C]sulpiride, a dopamine D2 receptor antagonist. J Pharm Sci S0022-3549(17)30359-3 [pii] https:\/\/doi.org\/10.1016\/j.xphs.2017.05.006","DOI":"10.1016\/j.xphs.2017.05.006"},{"key":"449_CR163","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/s0306-4522(99)00373-5","volume":"94","author":"JH Tao-Cheng","year":"1999","unstructured":"Tao-Cheng JH, Zhou FC (1999) Differential polarization of serotonin transporters in axons versus soma-dendrites: an immunogold electron microscopy study. Neuroscience 94:821\u2013830. https:\/\/doi.org\/10.1016\/s0306-4522(99)00373-5","journal-title":"Neuroscience"},{"key":"449_CR164","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/s0014-2999(97)01393-9","volume":"340","author":"M Tatsumi","year":"1997","unstructured":"Tatsumi M, Groshan K, Blakely RD, Richelson E (1997) Pharmacological profile of antidepressants and related compounds at human monoamine transporters. Eur J Pharmacol 340:249\u2013258. https:\/\/doi.org\/10.1016\/s0014-2999(97)01393-9","journal-title":"Eur J Pharmacol"},{"key":"449_CR165","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/nrn1008","volume":"4","author":"GE Torres","year":"2003","unstructured":"Torres GE, Gainetdinov RR, Caron MG (2003) Plasma membrane monoamine transporters: structure, regulation and function. Nat Rev Neurosci 4:13\u201325","journal-title":"Nat Rev Neurosci"},{"key":"449_CR166","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/tpj.2010.75","volume":"12","author":"MV Tzvetkov","year":"2012","unstructured":"Tzvetkov MV, Saadatmand AR, Bokelmann K, Meineke I, Kaiser R, Brockm\u00f6ller J (2012) Effects of OCT1 polymorphisms on the cellular uptake, plasma concentrations and efficacy of the 5-HT(3) antagonists tropisetron and ondansetron. Pharmacogenomics J 12:22\u201329. tpj201075 [pii]. https:\/\/doi.org\/10.1038\/tpj.2010.75","journal-title":"Pharmacogenomics J"},{"key":"449_CR167","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.bcp.2013.06.019","volume":"86","author":"MV Tzvetkov","year":"2013","unstructured":"Tzvetkov MV, dos Santos Pereira JN, Meineke I, Saadatmand AR, Stingl JC, Brockm\u00f6ller J (2013) Morphine is a substrate of the organic cation transporter OCT1 and polymorphisms in OCT1 gene affect morphine pharmacokinetics after codeine administration. Biochem Pharmacol 86:666\u2013678. S0006-2952(13)00390-0 [pii]. https:\/\/doi.org\/10.1016\/j.bcp.2013.06.019","journal-title":"Biochem Pharmacol"},{"key":"449_CR168","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1002\/cpt.812","volume":"103","author":"MV Tzvetkov","year":"2018","unstructured":"Tzvetkov MV, Matthaei J, Pojar S, Faltraco F, Vogler S, Prukop T, Seitz T, Brockm\u00f6ller J (2018) Increased systemic exposure and stronger cardiovascular and metabolic adverse reactions to fenoterol in individuals with heritable OCT1 deficiency. Clin Pharmacol Ther 103:868\u2013878. https:\/\/doi.org\/10.1002\/cpt.812","journal-title":"Clin Pharmacol Ther"},{"key":"449_CR169","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1111\/jnc.13758","volume":"139","author":"T Usui","year":"2016","unstructured":"Usui T, Nakazawa A, Okura T, Deguchi Y, Akanuma SI, Kubo Y, Hosoya KI (2016) Histamine elimination from the cerebrospinal fluid across the blood-cerebrospinal fluid barrier: involvement of plasma membrane monoamine transporter (PMAT\/SLC29A4). J Neurochem 139:408\u2013418. https:\/\/doi.org\/10.1111\/jnc.13758","journal-title":"J Neurochem"},{"key":"449_CR170","doi-asserted-by":"publisher","first-page":"2846","DOI":"10.1523\/JNEUROSCI.5147-03.2004","volume":"24","author":"V Vialou","year":"2004","unstructured":"Vialou V, Amphoux A, Zwart R, Giros B, Gautron S (2004) Organic cation transporter 3 (Slc22a3) is implicated in salt-intake regulation. J Neurosci 24:2846\u20132851","journal-title":"J Neurosci"},{"key":"449_CR171","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.neuroscience.2006.09.058","volume":"144","author":"V Vialou","year":"2007","unstructured":"Vialou V, Balasse L, Dumas S, Giros B, Gautron S (2007) Neurochemical characterization of pathways expressing plasma membrane monoamine transporter in the rat brain. Neuroscience 144:616\u2013622. https:\/\/doi.org\/10.1016\/j.neuroscience.2006.09.058","journal-title":"Neuroscience"},{"key":"449_CR172","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1111\/j.1471-4159.2008.05506.x","volume":"106","author":"V Vialou","year":"2008","unstructured":"Vialou V, Balasse L, Callebert J, Launay J-M, Giros B, Gautron S (2008) Altered aminergic neurotransmission in the brain of organic cation transporter 3-deficient mice. J Neurochem 106:1471\u20131482","journal-title":"J Neurochem"},{"key":"449_CR173","doi-asserted-by":"publisher","unstructured":"Wagner DJ, Sager JE, Duan H, Isoherranen N, Wang J (2017) Interaction and transport of methamphetamine and its primary metabolites by organic cation and multidrug and toxin extrusion transporters. Drug Metab Dispos. dmd.116.074708 [pii]. https:\/\/doi.org\/10.1124\/dmd.116.074708","DOI":"10.1124\/dmd.116.074708"},{"key":"449_CR174","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1002\/cpt.442","volume":"100","author":"J Wang","year":"2016","unstructured":"Wang J (2016) The plasma membrane monoamine transporter (PMAT): structure, function, and role in organic cation disposition. Clin Pharmacol Ther 100:489\u2013499. https:\/\/doi.org\/10.1002\/cpt.442","journal-title":"Clin Pharmacol Ther"},{"key":"449_CR175","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0306-4522(90)90217-r","volume":"39","author":"GV Williams","year":"1990","unstructured":"Williams GV, Millar J (1990) Concentration-dependent actions of stimulated dopamine release on neuronal activity in rat striatum. Neuroscience 39:1\u201316. https:\/\/doi.org\/10.1016\/0306-4522(90)90217-r","journal-title":"Neuroscience"},{"key":"449_CR176","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1021\/jm301302s","volume":"56","author":"MB Wittwer","year":"2013","unstructured":"Wittwer MB, Zur AA, Khuri N, Kido Y, Kosaka A, Zhang X, Morrissey KM, Sali A, Huang Y, Giacomini KM (2013) Discovery of potent, selective multidrug and toxin extrusion transporter 1 (MATE1, SLC47A1) inhibitors through prescription drug profiling and computational modeling. J Med Chem 56:781\u2013795. https:\/\/doi.org\/10.1021\/jm301302s","journal-title":"J Med Chem"},{"key":"449_CR177","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/s0378-1119(99)00143-2","volume":"233","author":"X Wu","year":"1999","unstructured":"Wu X, Gu HH (1999) Molecular cloning of the mouse dopamine transporter and pharmacological comparison with the human homologue. Gene 233:163\u2013170. https:\/\/doi.org\/10.1016\/s0378-1119(99)00143-2","journal-title":"Gene"},{"key":"449_CR178","doi-asserted-by":"publisher","first-page":"32776","DOI":"10.1074\/jbc.273.49.32776","volume":"273","author":"X Wu","year":"1998","unstructured":"Wu X, Kekuda R, Huang W, Fei YJ, Leibach FH, Chen J, Conway SJ, Ganapathy V (1998a) Identity of the organic cation transporter OCT3 as the extraneuronal monoamine transporter (uptake2) and evidence for the expression of the transporter in the brain. J Biol Chem 273:32776\u201332786. https:\/\/doi.org\/10.1074\/jbc.273.49.32776","journal-title":"J Biol Chem"},{"key":"449_CR179","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1006\/bbrc.1998.8669","volume":"246","author":"X Wu","year":"1998","unstructured":"Wu X, Prasad PD, Leibach FH, Ganapathy V (1998b) cDNA sequence, transport function, and genomic organization of human OCTN2, a new member of the organic cation transporter family. Biochem Biophys Res Commun 246:589\u2013595. https:\/\/doi.org\/10.1006\/bbrc.1998.8669","journal-title":"Biochem Biophys Res Commun"},{"key":"449_CR180","doi-asserted-by":"publisher","first-page":"F449","DOI":"10.1152\/ajprenal.2000.279.3.F449","volume":"279","author":"X Wu","year":"2000","unstructured":"Wu X, Huang W, Ganapathy ME, Wang H, Kekuda R, Conway SJ, Leibach FH, Ganapathy V (2000) Structure, function, and regional distribution of the organic cation transporter OCT3 in the kidney. Am J Physiol Renal Physiol 279:F449\u2013F458","journal-title":"Am J Physiol Renal Physiol"},{"key":"449_CR181","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1111\/jnc.13363","volume":"135","author":"KC Wu","year":"2015","unstructured":"Wu KC, Lu YH, Peng YH, Hsu LC, Lin CJ (2015a) Effects of lipopolysaccharide on the expression of plasma membrane monoamine transporter (PMAT) at the blood-brain barrier and its implications to the transport of neurotoxins. J Neurochem 135:1178\u20131188. https:\/\/doi.org\/10.1111\/jnc.13363","journal-title":"J Neurochem"},{"key":"449_CR182","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/jcbfm.2014.162","volume":"35","author":"KC Wu","year":"2015","unstructured":"Wu KC, Lu YH, Peng YH, Tsai TF, Kao YH, Yang HT, Lin CJ (2015b) Decreased expression of organic cation transporters, Oct1 and Oct2, in brain microvessels and its implication to MPTP-induced dopaminergic toxicity in aged mice. J Cereb Blood Flow Metab 35:37\u201347. jcbfm2014162 [pii]. https:\/\/doi.org\/10.1038\/jcbfm.2014.162","journal-title":"J Cereb Blood Flow Metab"},{"key":"449_CR183","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1021\/cn500331z","volume":"6","author":"SC Wyler","year":"2015","unstructured":"Wyler SC, Donovan LJ, Yeager M, Deneris E (2015) Pet-1 controls tetrahydrobiopterin pathway and Slc22a3 transporter genes in serotonin neurons. ACS Chem Nerosci 6:1198\u20131205. https:\/\/doi.org\/10.1021\/cn500331z","journal-title":"ACS Chem Nerosci"},{"key":"449_CR184","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/74839","volume":"3","author":"F Xu","year":"2000","unstructured":"Xu F, Gainetdinov RR, Wetsel WC, Jones SR, Bohn LM, Miller GW, Wang YM, Caron MG (2000) Mice lacking the norepinephrine transporter are supersensitive to psychostimulants. Nat Neurosci 3:465\u2013471. https:\/\/doi.org\/10.1038\/74839","journal-title":"Nat Neurosci"},{"key":"449_CR185","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/164_2016_13","volume":"241","author":"T Yoshikawa","year":"2017","unstructured":"Yoshikawa T, Yanai K (2017) Histamine clearance through polyspecific transporters in the brain. Handb Exp Pharmacol 241:173\u2013187. https:\/\/doi.org\/10.1007\/164_2016_13","journal-title":"Handb Exp Pharmacol"},{"key":"449_CR186","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1002\/glia.22484","volume":"61","author":"T Yoshikawa","year":"2013","unstructured":"Yoshikawa T, Naganuma F, Iida T, Nakamura T, Harada R, Mohsen AS, Kasajima A, Sasano H, Yanai K (2013) Molecular mechanism of histamine clearance by primary human astrocytes. Glia 61:905\u2013916. https:\/\/doi.org\/10.1002\/glia.22484","journal-title":"Glia"},{"key":"449_CR187","first-page":"354","volume":"286","author":"L Zhang","year":"1998","unstructured":"Zhang L, Schaner ME, Giacomini KM (1998) Functional characterization of an organic cation transporter (hOCT1) in a transiently transfected human cell line (HeLa). J Pharmacol Exp Ther 286:354\u2013361","journal-title":"J Pharmacol Exp Ther"},{"key":"449_CR188","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/s0006-8993(98)00691-x","volume":"805","author":"FC Zhou","year":"1998","unstructured":"Zhou FC, Tao-Cheng JH, Segu L, Patel T, Wang Y (1998) Serotonin transporters are located on the axons beyond the synaptic junctions: anatomical and functional evidence. Brain Res 805:241\u2013254. https:\/\/doi.org\/10.1016\/s0006-8993(98)00691-x","journal-title":"Brain Res"},{"key":"449_CR189","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/s0006-8993(02)02709-9","volume":"942","author":"FC Zhou","year":"2002","unstructured":"Zhou FC, Lesch KP, Murphy DL (2002) Serotonin uptake into dopamine neurons via dopamine transporters: a compensatory alternative. Brain Res 942:109\u2013119. https:\/\/doi.org\/10.1016\/s0006-8993(02)02709-9","journal-title":"Brain Res"},{"key":"449_CR190","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.neuron.2005.02.010","volume":"46","author":"FM Zhou","year":"2005","unstructured":"Zhou FM, Liang Y, Salas R, Zhang L, De Biasi M, Dani JA (2005) Corelease of dopamine and serotonin from striatal dopamine terminals. Neuron 46:65\u201374. https:\/\/doi.org\/10.1016\/j.neuron.2005.02.010","journal-title":"Neuron"},{"key":"449_CR191","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.bcp.2006.09.008","volume":"73","author":"M Zhou","year":"2007","unstructured":"Zhou M, Engel K, Wang J (2007) Evidence for significant contribution of a newly identified monoamine transporter (PMAT) to serotonin uptake in the human brain. Biochem Pharmacol 73:147\u2013154. https:\/\/doi.org\/10.1016\/j.bcp.2006.09.008","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"449_CR192","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1471-4159.2010.06738.x","volume":"114","author":"H-J Zhu","year":"2010","unstructured":"Zhu H-J, Appel DI, Gr\u00fcndemann D, Markowitz JS (2010) Interaction of organic cation transporter 3 (SLC22A3) and amphetamine. J Neurochem 114(1):142\u2013149","journal-title":"J Neurochem"},{"key":"449_CR193","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.phrs.2012.01.008","volume":"65","author":"HJ Zhu","year":"2012","unstructured":"Zhu HJ, Appel DI, Grundemann D, Richelson E, Markowitz JS (2012) Evaluation of organic cation transporter 3 (SLC22A3) inhibition as a potential mechanism of antidepressant action. Pharmacol Res 65:491\u2013496. https:\/\/doi.org\/10.1016\/j.phrs.2012.01.008","journal-title":"Pharmacol Res"},{"key":"449_CR194","doi-asserted-by":"publisher","unstructured":"Zhu P, Ye Z, Guo D, Xiong Z, Huang S, Guo J, Zhang W, Polli JE, Zhou H, Li QS, Hu Y (2018) Irinotecan alters the disposition of morphine via inhibition of organic cation transporter 1 (OCT1) and 2 (OCT2). Pharm Res 35:243. https:\/\/doi.org\/10.1007\/s11095-018-2526-y","DOI":"10.1007\/s11095-018-2526-y"},{"key":"449_CR195","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/s0165-0173(97)00048-9","volume":"26","author":"M Zoli","year":"1998","unstructured":"Zoli M, Torri C, Ferrari R, Jansson A, Zini I, Fuxe K, Agnati LF (1998) The emergence of the volume transmission concept. Brain Res Brain Res Rev 26:136\u2013147. https:\/\/doi.org\/10.1016\/s0165-0173(97)00048-9","journal-title":"Brain Res Brain Res Rev"},{"key":"449_CR196","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s00210-008-0369-5","volume":"379","author":"O Zolk","year":"2009","unstructured":"Zolk O, Solbach TF, Konig J, Fromm MF (2009a) Structural determinants of inhibitor interaction with the human organic cation transporter OCT2 (SLC22A2). Naunyn Schmiedebergs Arch Pharmacol 379:337\u2013348. https:\/\/doi.org\/10.1007\/s00210-008-0369-5","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"449_CR197","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1124\/dmd.108.023762","volume":"37","author":"O Zolk","year":"2009","unstructured":"Zolk O, Solbach TF, K\u00f6nig J, Fromm MF (2009b) Functional characterization of the human organic cation transporter 2 variant p.270Ala>Ser. Drug Metab Dispos 37:1312\u20131318","journal-title":"Drug Metab Dispos"}],"container-title":["Handbook of Experimental Pharmacology","Organic Cation Transporters in the Central Nervous System"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/164_2021_449","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,24]],"date-time":"2023-10-24T09:09:02Z","timestamp":1698138542000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/164_2021_449"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"ISBN":["9783030829834","9783030829841"],"references-count":197,"URL":"https:\/\/doi.org\/10.1007\/164_2021_449","relation":{},"ISSN":["0171-2004","1865-0325"],"issn-type":[{"value":"0171-2004","type":"print"},{"value":"1865-0325","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"30 March 2021","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}